MediWound Ltd.
NASDAQ:MDWDBiotechnology
-$0.09 today
- Market cap
- $176.61M
- Beta
- 0.15
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$2.03
Volume 0.16M
Average 0.09M
Returns on capital
MediWound Ltd. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-54.7%
avg -66.3%
ROIC
-41.3%
avg -39.8%
ROA
-27.7%
avg -32.0%
Analysis
ROA is currently the strongest return metric at -27.7% versus its period average of -32.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Ofer Gonen | Chief Executive Officer | USD 834K | 53 | 0 | <0.01% |
Ety Klinger | Chief Medical Officer | USD 428K | 64 | 1.50K | 0.01% |
Shmulik Hess | Chief Operating Officer & Chief Commercial Officer | USD 426K | 52 | — | — |
Hani Luxenburg | Chief Financial Officer | USD 420K | 52 | — | — |
Yaron Meyer Adv. | Executive Vice President, General Counsel & Corporate Secretary | USD 337K | 47 | — | — |
Liron Gal | Vice President of Manufacturing Science & Technology | — | — | — | — |
Robert J. Snyder FFPM | Senior Vice President of Global Medical Affairs | — | 75 | — | — |
Barry J. Wolfenson | Executive Vice President of Strategy & Corporate Development | — | 59 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 11, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
7
$142,671.19
Sells
4
$82,072.23
Net Transaction Value
+$60,598.96
Net buying
Most Active
Rubinstein Samuel
3 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Sep 1, 26Sep 1, 2026 | Rubinstein Samuel Indirect | Buy | $6.6K$6,625.50 |
| Sep 1, 26Sep 1, 2026 | Rubinstein Samuel Indirect | Sell | $6.7K$6,678.00 |
| Aug 27, 26Aug 27, 2026 | Hess Shmuel Direct | Sell | $25.2K$25,172.88 |
| Aug 27, 26Aug 27, 2026 | Hess Shmuel Direct | Sell | $26K$25,976.35 |
| Aug 26, 26Aug 26, 2026 | Hess Shmuel Direct | Sell | $24.2K$24,245.00 |
| Jun 3, 26Jun 3, 2026 | SHAMIR NACHUM Direct | Buy | $2.4K$2,445.63 |
| Jun 3, 26Jun 3, 2026 | SHAMIR NACHUM Direct | Buy | $81.6K$81,550.00 |
| Jun 1, 26Jun 1, 2026 | Fox David Morton Direct | Buy | $25.1K$25,149.02 |
| Jun 1, 26Jun 1, 2026 | Fox David Morton Direct | Buy | $24.6K$24,609.25 |
| Jun 1, 26Jun 1, 2026 | Fox David Morton Direct | Buy | $142.3$142.30 |
1–10 of 11
Summary
Insiders reported 7 buys worth $142,671.19 and 4 sells worth $82,072.23 over the last 12 months. That adds up to net buying of $60,598.96. Rubinstein Samuel was the most active insider with 3 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -13.8% | +59.0% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at -13.8% over three years. Forward estimates point to Revenue at +59.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does MediWound Ltd. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about MDWD's management, answered from reported figures.
Who manages MDWD?
MediWound Ltd. (MDWD) lists 8 active executives. The top listed executive is Ety Klinger, Chief Medical Officer.
Are MDWD insiders buying or selling?
Recent insider activity shows net selling of $69,468.24.
Continue the stock analysis
Jump to another research area for this company.